FDA Inspection 1224307 — Carl P. Griffin, M.D.
The FDA completed an inspection of Carl P. Griffin, M.D. on November 17, 2023 in Oklahoma City, OK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 17, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Oklahoma City, OK (United States)
Additional Details
Clinical Investigator (CI)